{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-004199","form_type":"8-K/A","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2024-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.557307+00:00","generated_at":"2026-06-06T22:27:00.114220+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ABVC BioPharma amends convertible note; corrects conversion price, discloses placement agent warrants","bullets":["Secured convertible note $1.2M principal issued to Lind Global Fund II for $1M purchase price.","Conversion price amended to lesser of $3.50 fixed or 90% of avg of three lowest VWAPs in prior 20 days.","First 180 days conversions at fixed $3.50 price if no event of default, per amendment dated Jan 12, 2024.","Issued Allele Capital placement agent warrants for 30,000 shares at $2.00 per share.","Lender waives any prior events of default under the transaction documents."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-004199","json":"https://secwatch.observer/filing/0001213900-24-004199.json","markdown":"https://secwatch.observer/filing/0001213900-24-004199.md","text":"https://secwatch.observer/filing/0001213900-24-004199.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024004199/0001213900-24-004199-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024004199/ea191466-8ka1_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T22:27:00.114220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"287b0042ebe2a51e7dd9ad3d1a6cb6007a3f21f6","claim":"ABVC BIOPHARMA, INC. amended amendment to the Note with Lind Global Fund II, LP.","evidence_excerpt":"ntered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with Lind Global Fund II, LP (“ Lind ”), pursuant to which the Company issued Lind a secured, convertible note in the principal amount of $1,200,000 (the “ Offering ”),","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024004199/0001213900-24-004199-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Lind Global Fund II, LP"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}